HBM Holdings Limited (HKG:2142)
Hong Kong · Delayed Price · Currency is HKD 11.69
-0.10 (-0.85%)
Feb 13, 2026, 4:08 PM HKT
HBM Holdings Market Cap
HBM Holdings has a market cap or net worth of 9.77 billion as of February 13, 2026. Its market cap has increased by 320.86% in one year.
Market Cap
9.77B
Enterprise Value
7.77B
Revenue
908.35M
Ranking
n/a
PE Ratio
16.17
Stock Price
11.69
Market Cap Chart
Since December 10, 2020, HBM Holdings's market cap has increased from 8.46B to 9.77B, an increase of 15.45%. That is a compound annual growth rate of 2.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 9.77B | -3.92% |
| Dec 31, 2025 | 10.17B | 646.35% |
| Dec 31, 2024 | 1.36B | -3.91% |
| Dec 29, 2023 | 1.42B | -32.16% |
| Dec 30, 2022 | 2.09B | -63.14% |
| Dec 31, 2021 | 5.67B | -30.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Everest Medicines | 13.91B |
| Nanjing Leads Biolabs | 12.66B |
| Guangzhou Innogen Pharmaceutical Group | 12.62B |
| Shanghai Haohai Biological Technology | 11.10B |
| Abbisko Cayman | 9.05B |
| Alphamab Oncology | 8.86B |
| Lepu Biopharma | 8.77B |
| CStone Pharmaceuticals | 8.25B |